FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...
NEW YORK (Reuters Health) - As a treatment for muscle stiffness in children with cerebral palsy, shots of botulinum toxin A, best known by the brand name Botox, are safe and produce measurable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results